UNSPSC 51391803: Mephentermine

This classification denotes a cns stimulant with the molecular formula C11H17N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TEZ91L71V4, chemically known as phenethylamine, n,alpha,alpha-trimethyl- but generally known as mephentermine, which bears US NIH Compound Identifier 3677. European Medicines Agency schedules Mephentermine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08748MIG.

UNSPSC 51391803 Mephentermine is a Commodity code that covers pharmaceutical products, though the recent state and local solicitation activity under this code shows a mismatch with its nominal scope. Seminole County, Florida's recent IFB for naloxone and drug deactivation systems (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) is tagged to this mephentermine code but represents procurement of emergency opioid-reversal medication and harm-reduction equipment rather than the sympathomimetic agent the code nominally describes. State and local buyers using this code appear to include county health departments and community health entities focused on substance-abuse response and overdose prevention. The naloxone procurement demonstrates quarterly delivery cycles with specific volume commitments—1,900 units annually in the Seminole County example—and vendors must absorb shipping and delivery costs as part of their pricing.

Geographic activity is limited in the recent record to Florida, with Seminole County as the identifiable buyer. The Seminole County solicitation required electronic bid submission through the county's e-Procurement Portal, standard compliance certifications (drug-free workplace, E-Verify), and standard insurance coverages including workers' compensation and commercial general liability. The contract structure offered a two-year initial term with a one-year renewal option and included a three-month probationary termination period. Potential FEMA funding introduced federal environmental compliance requirements (Clean Air Act, Federal Water Pollution Control Act). No explicit set-aside or disadvantaged-enterprise designations were specified in the Seminole County opportunity. Activity under this code appears limited; practitioners should verify whether the mephentermine code is the correct classification for naloxone and drug-deactivation procurement in other jurisdictions or whether recent opportunities in this family reflect a broader pattern or a single county's coding error.